Allergovaktsina peroral low-dose AV-1P

General characteristics. Structure:

Active ingredients (in a ratio 2:1:1:1): 0,02 mkg of allergen from house D4 dust, 0,01 mkg of allergen from a feather of pillows of D4, 0,01 mkg of allergen from a tick of D. рteronyssinus D4, 0,01 mkg of allergen from library D4 dust.

Excipients: microcrystallic cellulose.

Complex extract from various allergic agents for performing antiallergic therapy.

Pharmacological properties:

Pharmacodynamics. Reception of a peroral low-dose allergovaktsina of AV - 1P modifies the specific allergic answer, has the desensibilizing effect, reduces specific cellular and fabric reactivity, prevents development of allergic symptomatology.

Indications to use:

Complex therapy of allergic rhinitis, allergic bronchial asthma, caused by hypersensitivity to the allergens which are a part of an allergovaktsina, patients aged from 18 up to 55 years.

Route of administration and doses:

To take a pill regardless of meal. To place a tablet in an oral cavity and to rassasyvat within 1-2 minutes, then to swallow.

To carry out reception of a peroral allergovaktsina according to the following scheme:

1st month of treatment (phase of set of a dose): the 1st week - on 1 tablet a day; 2-ya-4-ya weeks - on 2 tablets a day.

With 2nd for the 6th months of treatment (a phase of maintenance doses) - on 2 tablets 2 times a week (for example, Monday and Friday).

The total course dose of a peroral low-dose allergovaktsina will make 6,85 mkg - 685 PNU. The recommended scheme of reception can be changed by the allergologist according to individual indications.

Features of use:

The patient should observe the eliminative (hypoallergenic) mode - actions for restriction of contact with the allergens which are a part of an allergovaktsina and also with the environment factors provoking allergy symptoms (dust, smoke, pungent smells).

Side effects:

Emergence of side effects is noted. At emergence of any allergic reactions during treatment to address the allergologist.

Interaction with other medicines:

Clinically significant interaction of an allergovaktsina with other medicines is not established.

Contraindications:

• period of an aggravation and heavy course of bronchial asthma;
• exacerbations of the accompanying serious illness, malignant new growths, acute infectious diseases and a sharpening of persistent infection;
• period of pregnancy and lactation.

Overdose:

Cases of overdose were not observed.

Storage conditions:

In the place protected from moisture and light at a temperature from 2 ºС to 8 ºС. Not to freeze. To store in the place, unavailable to children. A period of validity - 3 years. Not to apply after the termination of a period of validity.

Issue conditions:

Without recipe

Packaging:

On 30, 50 or 100 tablets in bank in packaging No. 1.